NATCO Pharma Limited (BOM:524816)
India · Delayed Price · Currency is INR | Market Cap | 181.96B +25.5% |
| Revenue (ttm) | 43.76B -1.3% |
| Net Income | 14.19B -24.8% |
| EPS | 79.20 -24.8% |
| Shares Out | n/a |
| PE Ratio | 12.83 |
| Forward PE | 24.38 |
| Dividend | 5.00 (0.49%) |
| Ex-Dividend Date | Feb 18, 2026 |
| Volume | 190,830 |
| Open | 1,175.00 |
| Previous Close | 1,175.60 |
| Day's Range | 1,001.05 - 1,200.00 |
| 52-Week Range | 789.30 - 1,226.10 |
| Beta | n/a |
| Analysts | Hold |
| Price Target | 957.89 (-5.79%) |
| Earnings Date | May 29, 2026 |
About NATCO Pharma
NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. It also provides orthopedic products... [Read more]
Financial Performance
In fiscal year 2026, NATCO Pharma's revenue was 43.76 billion, a decrease of -1.26% compared to the previous year's 44.32 billion. Earnings were 14.19 billion, a decrease of -24.76%.
Financial StatementsNews
NATCO Pharma Transcript: Q4 25/26
FY26 saw a decline in revenue and profit due to lower Revlimid sales and increased competition, with a one-time tax benefit partially offsetting the drop. FY27 is expected to be a muted year, but growth is projected to resume from FY28, driven by new launches and global diversification.
NATCO Pharma Quarterly report: Q4 2026
NATCO Pharma has published its Q4 2026 quarterly earnings report on May 29, 2026.
NATCO Pharma Slides: Q4 2026
NATCO Pharma has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 29, 2026.
Top losers today: life insurance corporation at ₹411.35 plunges 50.44%, natco pharma at ₹1,015.90 down 13.60%, jyoti CNC at ₹596.00 falls 9.28%
The Indian stock market witnessed a downturn today, with both the SENSEX and NIFTY 50 indices experiencing declines of 1.44% and 1.50%, respectively. Among the top losers, Life Insurance Corporation…
Pharma sector stocks fall today, May 18: Alembic Pharma crashes 8.32%, Natco Pharma down 2.48%, Aarti Drugs declines 2.27%
Indian pharmaceutical stocks traded mostly lower on May 18 2026 during the morning session. The BSE Healthcare index declined 0.87% to 46,781.22, in line with the broader market weakness. The…
Pharma sector stocks today, May 8: Indoco Remedies falls 6%, Natco Pharma jumps 2.57%, Mankind Pharma up 2.43%
Indian pharmaceutical stocks showed mixed performance in early trading on May 8, 2026. The S&P BSE Healthcare index was up 0.26% at 46,515.42, while the broader market declined, with Nifty…
Pharma sector stocks today, May 5: Wockhardt surges over 8%, Strides Pharma rises 1.81%, Natco Pharma up 1.36%
India's pharmaceutical sector showed a mixed opening on May 5, 2026, with the S&P BSE Healthcare index trading at 45,222.25, down 0.10% in early trade. While most pharma counters were…
Pharma sector stocks today, April 22: Natco Pharma up 1.4%, Lupin falls 1.01%, Cipla down 0.73%
The Indian pharmaceutical sector opened on a mixed note on April 22, 2026. The NIFTY PHARMA Index was trading at 22,403.2, down 0.2%, while the S&P BSE Healthcare Index stood…
Pharma sector stocks today, April 21: Wockhardt surge 2.08%, Natco Pharma down 1.86%, Ajanta Pharma up 1.10%
The Indian pharma sector opened on a mixed note on April 21, 2026 (as of 9:43 AM). The S&P BSE Healthcare Index stood at 43,475.50, up 0.23%, while the NIFTY…
Pharma sector stocks today, April 17: Natco Pharma jumps 3.81%, Alembic Pharma up 2.14%, Strides Pharma rises 1.27%
The S&P BSE Healthcare index opened the session marginally in the green at 43,254.35, up 0.02%, while the broader Sensex traded at 78,084.52, up 0.12%. The Nifty 50 was nearly…
Pharma sector stocks today, March 25: Wockhardt surge 7.40%, Senores Pharma up 5.95%, Natco Pharma jumps 3.32%
Several pharmaceutical stocks traded higher in early morning sessions on the BSE and NSE. The S&P BSE Healthcare Index stood at 42,461.1, reflecting a gain of 1.4% for the day.…
Pharma sector stocks rally sharply today, March 25: Wockhardt surge 7.40%, Senores Pharma up 5.95%, Natco Pharma jumps 3.32%
Several pharmaceutical stocks traded higher in early morning sessions on the BSE and NSE. The S&P BSE Healthcare Index stood at 42,461.1, reflecting a gain of 1.4% for the day.…
Natco Pharma shares surge over 3% after board approves demerger of agrochemicals business
Natco Pharma shares gained over 3% in early trade on March 25 after the company announced a key corporate restructuring plan along with other strategic decisions. The company informed exchanges…
Top Stocks For Trade Today, March 25: United Spirits, Sammaan Capital, Kotak Mahindra Bank, Natco Pharma, OMC, Paint Stocks
Indian markets are likely to track global cues amid easing crude prices, with several stock-specific developments expected to drive action today. Brent crude has continued its decline for a second…
Eris Lifesciences partners with Natco Pharma for semaglutide launch in India
Eris Lifesciences Limited has announced a strategic partnership with Natco Pharma Limited to commercialise Semaglutide in India. This move aims to bolster Eris's leadership in the rapidly expanding di...
Pharma sector stocks surge today, March 20: Laurus Labs jumps 2.83%, Natco Pharma up 2.67%, Aurobindo Pharma gains 2.42%
The pharmaceutical sector in India showed positive movement on March 20, 2026, during early trading hours. The S&P BSE HEALTHCARE Index stood at 42,149.5, reflecting a gain of 1.1%. This…
Natco Pharma launches Semaglutide generic injection in India at Rs 1,290
Natco Pharma Limited has announced the launch of its generic Semaglutide injection in India, available from March 21, 2026. The product, offered in multi-dose vials, is priced at a starting…
Natco Pharma to consider agri business demerger on March 24
Natco Pharma Limited has informed exchanges that its board of directors will meet on March 24, 2026, to consider a proposal for the demerger of its agri business. The company,…
Pharma sector stocks today, March 11: Natco Pharma falls 1.35%, Alembic Pharma surge 1.33%, Glenmark Pharma up 1.41%
The Pharmaceuticals sector stocks in India showed mixed performance on March 11, 2026, during early trading hours. Data is based on prices as of approximately 9:43 AM IST for BSE…
Pharma sector stocks surge today, March 10: Natco Pharma up 4%, Granules India jumps 3.31%, Glenmark Pharma rises 2.72%
The pharmaceutical sector in India showed positive movement on March 10, 2026, during early trading hours, with many stocks recording gains as of approximately 9:36 AM IST on BSE and…
Pharma sector stocks today, March 6: Shilpa Medicare surge 3.08%, Wockhardt jumps 2.12%, Natco Pharma up 1.84%,
The pharmaceutical sector in India showed mixed performance on March 6, 2026, during early trading hours. Data from around 9:46 AM to 9:50 AM IST indicated the S&P BSE HEALTHCARE…
Pharma sector stocks surge today, March 5: Natco Pharma jumps 3.35%, Granules India up 2.74%, Alembic surge nearly 2%
Pharmaceutical stocks in India showed mixed performance on March 5, 2026, during early trading hours, with many recording modest gains amid broader market movements. The S&P BSE HEALTHCARE Index stood...
Natco Pharma shares rise over 2% after launch of generic Pomalidomide Capsules in the US
Shares of Natco Pharma moved higher in early trade on Wednesday after the pharmaceutical company announced the launch of Pomalidomide Capsules in the United States in partnership with Breckenridge Pha...
Natco Pharma launches Generic Pomalidomide Capsules in US market
Natco Pharma Limited (BSE: 524816 | NSE: NATCOPHARM) has announced the launch of Pomalidomide Capsules in the United States in...
Pharma sector stocks down today, March 2: Morepen Lab falls 3.24%, Ajanta Pharma drops 2.32%, Natco Pharma down 2.26%
The Indian pharmaceutical sector experienced a sharp decline on March 2, 2026, with many stocks trading lower in early sessions....